Clinical trial
Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi…
NCT00346502 · University of Illinois at Chicago, Other · Withdrawn
Key facts
| NCT number | NCT00346502 |
|---|---|
| Title | Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia) |
| Official title | Phase I/II Evaluation of Topical Application of 20% Betulinic Acid Ointment in the Treatment of Dysplastic Nevi With Moderate to Severe Dysplasia |
| Lead sponsor | University of Illinois at Chicago, Other |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Dysplastic Nevus Syndrome |
| Intervention type | Drug |
| Interventions | 20% betulinic acid ointment, BA |
| Enrollment | 0 |
| Start date | Jan 1, 2006 |
| Primary completion | Dec 1, 2015 |
| Completion | Dec 1, 2015 |
| First posted | Jun 30, 2006 |
| Last update posted | Jun 28, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: